13F Holdings
中文EN

TNMG TNL Mediagene IFRS Annual reports only

Services-Advertising · Nasdaq · SEC CIK 2013186 · Fiscal year ends 12/31

Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY35.3%
TTM net income YoY-10,459.9%
TTM EPS YoY-8,550.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin36.6%
Operating margin-157.4%
Net margin-175.3%
FCF margin-21.2%
EBITDA margin-150.7%

Returns

ROE-155.9%
ROA-80.0%
ROIC (approx.)-102.0%
Asset turnover0.46x

Leverage & solvency

Liabilities / assets60.8%
Debt / equity0.27x
Current ratio0.54x
Interest coverage-9.35x

Cash quality & payout

Operating cash flow / net income0.12x
Accruals ratio-70.4%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20242024-12-31FY20232023-12-31FY20222022-12-31
Income statement
Revenue$48.49M$35.84M$20.01M
Cost of revenue$30.76M$23.19M$12.27M
Gross profit$17.74M$12.65M$7.74M
R&D expense$3.05M$3.33M$2.51M
SG&A expense$62.00M$16.42M$8.65M
Operating income-$76.34M-$7.40M-$3.42M
Interest expense$8.17M$298,958$137,029
Pretax income-$85.28M-$1.81M-$11.64M
Income tax-$307,246-$591,082-$247,177
Net income-$85.00M-$804,977-$11.01M
EBITDA-$73.10M-$4.56M—
EPS (basic)-3.46-0.04-1.20
EPS (diluted)-3.46-0.04-1.20
Balance sheet
Cash & equivalents$3.65M$3.03M$3.73M
Receivables$8.24M$8.85M—
Inventory$87,828$115,624—
Current assets$17.72M$16.85M—
PP&E, netmay include right-of-use assets (IFRS)$430,809$537,014$77,467
Goodwill$33.96M$60.74M—
Intangibles$30.98M$33.41M—
Total assets$92.92M$119.62M—
Current liabilities$32.99M$24.90M—
Short-term debt$4.84M$3.12M—
Long-term debt$4.84M$3.12M—
Total debt$9.69M$6.24M—
Total liabilities$56.51M$47.25M—
Shareholders' equity$36.40M$72.62M-$24.14M
Net debt$6.04M$3.21M—
Shares outstanding26.13M24.20M9.21M
Cash flow statement
Operating cash flow-$10.21M-$1.42M-$760,106
Capital expenditure$89,121$87,179$52,481
Free cash flow-$10.30M-$1.51M-$812,587
Investing cash flow$922,857$252,741-$2.36M
Financing cash flow$10.02M$530,972$4.99M
Depreciation & amortization$3.24M$2.84M—
Stock-based compensation$250,952$118,800$237,301

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.